MedTrace Logo

Using the ATC/DDD to Monitor Antibiotic Use at Lower Primary Care Facilities in Southwestern Uganda

NCT04782011 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1406

Last updated 2021-03-04

No results posted yet for this study

Summary

This is a non blinded two arm cluster randomized control trial, aimed at assessing the feasibility of using the Anatomical Therapeutic Chemical Classification/define Daily Doses system tool to monitor antibiotic use at lower primary levels of care in Uganda.

Conditions

  • ATC/DDD
  • Antibiotic Utilization

Interventions

BEHAVIORAL

ATC/DDD

The intervention is the introduction of the ATC/DDD including the training on its importance and usage in monitoring antibiotic use at a given primary care facility.

Sponsors & Collaborators

  • Swedish International Development Cooperation Agency (SIDA)

    collaborator OTHER_GOV

  • Mbarara University of Science and Technology

    collaborator OTHER

  • Makerere University

    lead OTHER

Principal Investigators

  • Jackson Mukonzo, PhD · Makerere University

  • Vincent Batwala, PhD · Mbarara University of Science and Technology

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-03-31
Primary Completion
2021-10-31
Completion
2021-11-30

Countries

  • Uganda

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04782011 on ClinicalTrials.gov